| 000 | 01607 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515115855.0 | ||
| 264 | 0 | _c20080715 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2008.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWolin, Ronald L | |
| 245 | 0 | 0 |
_aDual binding site inhibitors of B-RAF kinase. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cMay 2008 |
||
| 300 |
_a2825-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAllosteric Site |
| 650 | 0 | 4 | _aComputer-Aided Design |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHydrocarbons, Aromatic _xchemical synthesis |
| 650 | 0 | 4 |
_aImidazoles _xchemical synthesis |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBembenek, Scott D | |
| 700 | 1 | _aWei, Jianmei | |
| 700 | 1 | _aCrawford, Shelby | |
| 700 | 1 | _aLundeen, Katherine | |
| 700 | 1 | _aBrunmark, Anders | |
| 700 | 1 | _aKarlsson, Lars | |
| 700 | 1 | _aEdwards, James P | |
| 700 | 1 | _aBlevitt, Jonathan M | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 18 _gno. 9 _gp. 2825-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2008.04.002 _zAvailable from publisher's website |
| 999 |
_c17931158 _d17931158 |
||